TrademarkDir
CELULARITY
LIVE

Serial Number

87862993

Owner

CELENIV PTE. LTD.

Attorney

Camille M. Miller

First Use Date

Feb 21, 2018

Filing Date

Apr 4, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CELULARITY Trademark

Serial Number: 87862993 • Registration: 6102576

CELULARITY is a trademark filed by CELENIV PTE. LTD. on April 4, 2018. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CELENIV PTE. LTD. (13 trademarks)

3, LIM TECK KIM ROAD
SINGAPORE 088934 , SG

Entity Type: 11

CELULARITY, INC. (50 trademarks)

33 TECHNOLOGY DRIVE
WARREN, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

April 4, 2018

Registration Date

July 14, 2020

First Use Anywhere

February 21, 2018

First Use in Commerce

February 21, 2018

Published for Opposition

November 13, 2018

Goods & Services

Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing technical writing and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biological research, namely, biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 7, 2026 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 14, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 12, 2022 ASGN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 8, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 8, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 8, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 8, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 8, 2020 COAR
REGISTERED-PRINCIPAL REGISTER
Jul 14, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 12, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 11, 2020 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 26, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 26, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 26, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 22, 2020 GNFN
FINAL REFUSAL E-MAILED
May 22, 2020 GNFR
SU - FINAL REFUSAL - WRITTEN
May 22, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 30, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 4, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 4, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 4, 2019 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Nov 8, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 8, 2019 AITU
USE AMENDMENT FILED
Oct 28, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 28, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 11, 2019 EXRA
SOU EXTENSION 1 GRANTED
Jun 7, 2019 EX1G
SOU EXTENSION 1 FILED
Jun 7, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 7, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 8, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Nov 13, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 24, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 9, 2018 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 3, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 2, 2018 GNRN
NON-FINAL ACTION E-MAILED
Oct 2, 2018 GNRT
NON-FINAL ACTION WRITTEN
Oct 2, 2018 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 13, 2018 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 11, 2018 PBCR
ASSIGNED TO LIE
Aug 23, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 14, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 24, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jul 24, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jul 24, 2018 CNRT
ASSIGNED TO EXAMINER
Jul 23, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2018 NWOS
NEW APPLICATION ENTERED
Apr 7, 2018 NWAP

Related Trademarks

More from this Owner

BIOVANCE

BIOVANCE

BIOVANCE

BIOVANCE

BIOVANCE

BIOVANCE

BIOVANCE

BIOVANCE

AESTHETIC REGENERATIVE THERAPY (A.R.T.)

AESTHETIC REGENERATIVE THERAPY (A.R.T.)

AESTHETIC REGENERATIVE THERAPY (A.R.T.)

AESTHETIC REGENERATIVE THERAPY (A.R.T.)